Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer

被引：8
|
作者：
Choe, Jooae [1 ,2 ]
Braschi-Amirfarzan, Marta [3 ,4 ]
Tirumani, Sree Harsha [4 ]
Shinagare, Atul B. [3 ,4 ]
Kim, Kyung Won [1 ,2 ]
Ramaiya, Nikhil H. [3 ,4 ]
Krajewski, Katherine M. [3 ,4 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Imaging, 450 Brookline Ave, Boston, MA 02215 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA
来源：
ABDOMINAL RADIOLOGY | 2017年 / 42卷 / 11期
关键词：
Bladder cancer; Urothelial carcinoma; Diagnosis; Management; Oncologic imaging; COMPUTED-TOMOGRAPHY UROGRAPHY; GEMCITABINE PLUS CISPLATIN; URINARY-BLADDER; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; MDCT UROGRAPHY; CT UROGRAPHY; LYMPH-NODES; FOLLOW-UP; RECURRENCE;
D O I：
10.1007/s00261-017-1195-3
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Urothelial bladder cancer is a common malignancy requiring a multidisciplinary approach to treatment. Significant recent advances have been made in terms of the genetic and molecular characterization of bladder cancer subtypes, and novel treatment approaches are being investigated and approved. Given the important role of imaging in the diagnosis, staging, and follow-up of this disease, it is necessary for radiologists to remain up-to-date in terms of nomenclature and standards of care. In this review, recent developments in bladder cancer characterization and treatment will be discussed, with reference to the contributions of imaging in non-muscle-invasive, muscle-invasive, and metastatic settings.
引用
收藏
页码：2710 / 2724
页数：15
相关论文
共 50 条
  • [21] Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
    Shuaishuai Xu
    Qiuying Yao
    Guiqin Liu
    Di Jin
    Haige Chen
    Jianrong Xu
    Zhicheng Li
    Guangyu Wu
    European Radiology, 2020, 30 : 1804 - 1812
  • [22] Muscle-invasive bladder cancer
    Buchler, Jakob
    Gschwend, Juergen E.
    Retz, Margitta
    Schmid, Sebastian C.
    UROLOGE, 2021, 60 (06): : 769 - 775
  • [23] Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
    Xu, Shuaishuai
    Yao, Qiuying
    Liu, Guiqin
    Jin, Di
    Chen, Haige
    Xu, Jianrong
    Li, Zhicheng
    Wu, Guangyu
    EUROPEAN RADIOLOGY, 2020, 30 (03) : 1804 - 1812
  • [24] Metabolomics analysis of non-muscle invasive and muscle-invasive bladder cancer.
    Sahu, Divya
    Lotan, Yair
    Wittman, Bryan
    Neri, Bruce
    Hansel, Donna E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [25] Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy
    Chen, Shuo
    Zhu, Shanshan
    Cui, Xiaoyu
    Xu, Wenbin
    Kong, Chuize
    Zhang, Zhe
    Qian, Wei
    BIOMEDICAL OPTICS EXPRESS, 2019, 10 (07) : 3533 - 3544
  • [26] Quantitative Immunofluorescence Evaluation of PD-L1 Expression in Non-Muscle-Invasive and Muscle-Invasive Urothelial Bladder Cancer
    T. A. Bogush
    K. S. Spiridonova
    E. A. Bogush
    A. N. Grishanina
    A. M. Scherbakov
    M. I. Volkova
    Z. M. Safarov
    V. B. Matveev
    V. S. Kosorukov
    Moscow University Chemistry Bulletin, 2023, 78 : 338 - 343
  • [27] Quantitative Immunofluorescence Evaluation of PD-L1 Expression in Non-Muscle-Invasive and Muscle-Invasive Urothelial Bladder Cancer
    Bogush, T. A.
    Spiridonova, K. S.
    Bogush, E. A.
    Grishanina, A. N.
    Scherbakov, A. M.
    Volkova, M. I.
    Safarov, Z. M.
    Matveev, V. B.
    Kosorukov, V. S.
    MOSCOW UNIVERSITY CHEMISTRY BULLETIN, 2023, 78 (06) : 338 - 343
  • [28] Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
    Ma, Chengquan
    Lu, Bingxin
    Diao, Chengwen
    Zhao, Kun
    Wang, Xinpeng
    Ma, Baojing
    Lu, Baojian
    Sun, Erlin
    ONCOTARGETS AND THERAPY, 2016, 9 : 4917 - 4922
  • [29] Study on non-muscle-invasive Bladder Cancer Therapy
    Rexer, H.
    UROLOGE, 2016, 55 (04): : 528 - 531
  • [30] TIMELINE Landmarks in non-muscle-invasive bladder cancer
    Mertens, Laura S.
    Neuzillet, Yann
    Horenblas, Simon
    van Rhijn, Bas W. G.
    NATURE REVIEWS UROLOGY, 2014, 11 (08) : 476 - 480
12345